CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

被引:198
作者
Galli, G
Nuti, S
Tavarini, S
Galli-Stampino, L
De Lalla, C
Casorati, G
Dellabona, P
Abrignani, S
机构
[1] IRIS, Res Ctr, Chiron Vaccines, I-53100 Siena, Italy
[2] Ist Sci San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy
关键词
autoreactivity; cytokine; a-galactosylceramide; antibodies; helper assay;
D O I
10.1084/jem.20021616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant natural killer T (NKT) cells are a highly conserved subset of T lymphocytes expressing a semi-invariant T cell receptor (TCR), which is restricted to CD1d and specific for the glycosphingolipid antigen alpha-galactosylceramide. Their ability to secrete a variety of cytokines, which in turn modulate the activation of cells of both innate and acquired immune responses, suggests that invariant NKT cells exert a regulatory role mainly via indirect mechanisms. A relevant question is whether invariant NKT cells can directly help B cells. We document here that human invariant NKT cells are as efficient as conventional CD4(+) Th0 lymphocytes in promoting proliferation of autologous memory and naive B lymphocytes in vitro, and in inducing immunoglobulin production. Help to B cells by invariant NKT cells is CD1d-dependent and delivered also in the absence of a-galactosylceramide, suggesting that NKT cells recognize an endogenous ligand presented by CD1d on B cells. The two major subsets of invariant NKT cells, CD4(+) and double negative (CD4(-)CD8(-)), express comparable levels of CD40 ligand and cytokines, but differ in helper functions. Indeed, both subsets induce similar levels of B cell proliferation, whereas CD4(+) NKT cells induce higher levels of immunoglobulin production. These results suggest a direct role for invariant NKT cells in regulating B lymphocyte proliferation and effector functions.
引用
收藏
页码:1051 / 1057
页数:7
相关论文
共 30 条
  • [1] CD27: a memory B-cell marker
    Agematsu, K
    Hokibara, S
    Nagumo, H
    Komiyama, A
    [J]. IMMUNOLOGY TODAY, 2000, 21 (05): : 204 - 206
  • [2] Mouse CD1-specific NK1 T cells: Development, specificity, and function
    Bendelac, A
    Rivera, MN
    Park, SH
    Roark, JH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 535 - 562
  • [3] CD1d-restricted mouse Vα14 and human Vα24 T cells:: lymphocytes of innate immunity
    Benlagha, K
    Bendelac, A
    [J]. SEMINARS IN IMMUNOLOGY, 2000, 12 (06) : 537 - 542
  • [4] CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution
    Brossay, L
    Chioda, M
    Burdin, N
    Koezuka, Y
    Casorati, G
    Dellabona, P
    Kronenberg, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) : 1521 - 1528
  • [5] Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO
  • [6] 2-G
  • [7] Carnaud C, 1999, J IMMUNOL, V163, P4647
  • [8] Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells
    Cui, JQ
    Watanabe, N
    Kawano, T
    Yamashita, M
    Kamata, T
    Shimizu, C
    Kimura, M
    Shimizu, E
    Koike, J
    Koseki, H
    Tanaka, Y
    Taniguchi, M
    Nakayama, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) : 783 - 792
  • [9] Chemokines - Chemokines and cell migration in secondary lymphoid organs
    Cyster, JG
    [J]. SCIENCE, 1999, 286 (5447) : 2098 - 2102
  • [10] D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO